UBS Knock-Out TEVA/ DE000UM471T4 /
| 2024-06-07 7:36:27 PM | Chg.0.000 | Bid9:56:33 PM | Ask9:56:33 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.570EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
Teva Pharmaceutical ... | 22.605 USD | 2078-12-31 | Put |
Master data
| Issuer: | UBS AG, LONDON BRANCH |
|---|---|
| WKN: | UM471T |
| Currency: | EUR |
| Underlying: | Teva Pharmaceutical Industries Ltd |
| Type: | Knock-out |
| Option type: | Put |
| Strike price: | 22.605 USD |
| Maturity: | Endless |
| Issue date: | 2024-05-13 |
| Last trading day: | 2078-12-31 |
| Ratio: | 10:1 |
| Exercise type: | Bermuda |
| Quanto: | No |
| Gearing: | -2.63 |
| Knock-out: | 22.605 |
| Knock-out violated on: | - |
| Distance to knock-out: | -5.495 |
| Distance to knock-out %: | -36.01% |
| Distance to strike price: | -5.495 |
| Distance to strike price %: | -36.01% |
Calculated values
| Fair value: | - |
|---|---|
| Implied volatility: | - |
| Historic volatility: | - |
| Parity: | - |
| Time value: | - |
| Break-even: | - |
| Moneyness: | - |
| Premium: | 0.02 |
| Premium p.a.: | 0.00 |
| Spread abs.: | 0.01 |
| Spread %: | 1.75% |
| Delta: | - |
| Theta: | - |
| Omega: | - |
| Rho: | - |
Quote data
| Open: | 0.570 |
|---|---|
| High: | 0.590 |
| Low: | 0.000 |
| Market phase: | CL |
All quotes in EUR
Performance
| 1 Week | +1.79% | ||
|---|---|---|---|
| 1 Month | - | ||
| 3 Months | - | ||
| YTD | - | ||
| 1 Year | - | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| 1W High / 1W Low: | 0.570 | 0.540 |
|---|---|---|
| 1M High / 1M Low: | - | - |
| 6M High / 6M Low: | - | - |
| High (YTD): | - | - |
| Low (YTD): | - | - |
| 52W High: | - | - |
| 52W Low: | - | - |
| Avg. price 1W: | 0.558 | |
| Avg. volume 1W: | 0.000 | |
| Avg. price 1M: | - | |
| Avg. volume 1M: | - | |
| Avg. price 6M: | - | |
| Avg. volume 6M: | - | |
| Avg. price 1Y: | - | |
| Avg. volume 1Y: | - | |
| Volatility 1M: | - | |
| Volatility 6M: | - | |
| Volatility 1Y: | - | |
| Volatility 3Y: | - |
